More on PHAT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.5 Score)
- FDA

Upcoming Events

- Earnings (8/7/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Phathom Pharmaceuticals Inc. (NQ:PHAT)
Delayed: 10.67 -0.07 (0.65%)
Prev. Close $10.74  
Open$10.46 
52 Wk High$ 
52 Wk Low$ 
Day High$10.79 
Day Low$10.17 
P/E N/A  
EPS$ 
Volume965,762 

Friends, Peers and Foes (?): CDTX, HLVX, IPO SAGE (more...)

Mar 5, 2026 01:08 PM Phathom Pharmaceuticals Inc. (PHAT) spreader of 3K contracts of January 7.5 and 12.50 calls
Mar 4, 2026 05:46 PM H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
Mar 3, 2026 05:11 PM Form 4 Phathom Pharmaceuticals, For: Feb 27 Filed by: Breedlove Robert Charles
Feb 27, 2026 06:47 AM Phathom Pharmaceuticals (PHAT) PT Raised to $25 at Guggenheim
Feb 26, 2026 12:51 PM Stifel Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
Feb 26, 2026 07:36 AM Phathom Pharmaceuticals, Inc. (PHAT) Tops Q4 EPS by 34c
Feb 26, 2026 07:06 AM Form 10-K Phathom Pharmaceuticals, For: Dec 31
Feb 26, 2026 07:05 AM Form 8-K Phathom Pharmaceuticals, For: Feb 26
Feb 26, 2026 07:00 AM Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
Feb 23, 2026 08:00 AM Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
View All Articles

Entities mentioned with PHAT

View All Entities